NewsFeed Voices Science Insight Innovation
November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
NEJM Study: Aspirin with Oral Anticoagulation Raises Risks in Chronic Coronary Syndrome
Ahmed Bennis/X
Aug 31, 2025, 10:55

NEJM Study: Aspirin with Oral Anticoagulation Raises Risks in Chronic Coronary Syndrome

Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared a post on X:

”Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation

Among patients with chronic coronary syndrome at high atherothrombotic risk who were receiving an oral anticoagulant, the addition of aspirin led to a higher risk of cardiovascular death, myocardial infarction, stroke, systemic embolism, coronary revascularization, or acute limb ischemia than placebo, as well as higher risks.”

Read the full article here.

Title: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation

Authors: Gilles Lemesle, Romain Didier, Philippe Gabriel Steg, Tabassome Simon, Gilles Montalescot, Nicolas Danchin, Christophe Bauters, Didier Blanchard, Claire Bouleti, Denis Angoulvant, Stéphane Andrieu, Gérald Vanzetto, Mathieu Kerneis, Véronique Decalf, Etienne Puymirat, Dominique Mottier, Abdourahmane Diallo, Eric Vicaut, Martine Gilard, Guillaume Cayla

Aspirin Aspirin

Stay updated on the latest scientific advancements with Hemostasis Today.

Abdourahmane Diallo Ahmed Bennis Aspirin Atherothrombotic Risk Christophe Bauters Chronic Coronary Syndrome Claire Bouleti Denis Angoulvant Didier Blanchard Dominique Mottier Eric Vicaut Etienne Puymirat Gérald Vanzetto Gilles Lemesle Gilles Montalescot Guillaume Cayla Health Hemostasis Today Ischemia Martine Gilard Mathieu Kerneis Nicolas Danchin Oral Anticoagulant Philippe Gabriel Steg Placebo Romain Didier Stéphane Andrieu Tabassome Simon Véronique Decalf
NewsFeed